Insight journal - Company

Shionogi: Partnering activity 2005-2013

Posted on 13 December 2013

Tags: , ,

Shionogi announced over 30 partnering / licensing deals since 2005, with almost consistent dealmaking deals in 2010. Analysis of the partnering deals shows a strong emphasis on partnerships in infectives, CNS and respiratory diseases.

Abstracted from: Report: Partnering Agreements with Shionogi 2005-2013

The number of partnering, collaborative R&D and licensing deals announced were slow between 2005 and 2009 and gained momentum from 2010. Shionogi has already made 5 deal announcements this year.

The following figure shows the level of Shionogi partnering deal announcements since 2005.

Figure 1: Shionogi partnering deals 2005-2013

Figure 1: Shionogi partnering deals 2005-2013

 

Source: Current Agreements, 2013

Analysis of the partnering deals shows a strong emphasis on partnerships in infectives therapeutic disease area with a focus on HIV partnering deals.

Our report provides more detailed insight into the precise therapeutic target of each deal. See: Report: Partnering Agreements with Shionogi 2005-2013

Figure 2: Shionogi partnering deals by therapy area 2005-2013

Figure 2: Shionogi partnering deals by therapy area 2005-2013

 

Source: Current Agreements, 2013

Further analysis of these deals shows that Shionogi has a preference for licensing deal type activity. Such partnering deals provide the right for the company to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments. Shionogi entered into 31 licensing deals between 2005- 2013 alone.

The following table provides an overview of the partnering deals announced by Shionogi based on deal type disclosed.

Figure 3: Shionogi partnering deals by deal type 2005-2013

Figure 3: Shionogi partnering deals by deal type 2005-2013

 

Source: Current Agreements, 2013

The company is largely focussed on manufacturing and distribution of pharmaceutical products hence the discovery and marketed stages of development are shown to be popular stages of development for the company.

The following table provides an overview of the partnering deals announced by Shionogi based on stage of development at signature.

Figure 4: Shionogi partnering by stage of development 2005-2013

Figure 4: Shionogi partnering by stage of development 2005-2013

 

Source: Current Agreements, 2013

Shionogi has signed over 30 partnering, collaborative R&D and licensing deals since 2005. The following provides a summary of the top deals by headline value.

Figure 5: Top Shionogi partnering deals by headline value 2005-2013

Figure 5: Top Shionogi partnering deals by headline value 2005-2013

 

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal.

See: Report: Partnering Agreements with Shionogi 2005-2013

Shionogi partnering at Current Agreements

View all partnering deals for Shionogi: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report:

Report: Partnering Agreements with Shionogi 2005-2013

More

Summary profile data for Shionogi

Partnering interests for Shionogi

M&A activity for Shionogi

 

Available reports from Current Partnering

Report: Partnering Agreements with Shionogi 2005-2013

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

 

Available resources for deal coverage for Shionogi

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Shionogi company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

 

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply